OGI
Organigram Global Inc. Healthcare - Drug Manufacturers - Specialty & Generic Investor Relations →
Organigram Global Inc. (OGI) closed at $0.96 as of 2026-06-19, trading 48.9% below its 200-week moving average of $1.89. This places OGI in the extreme value zone. The stock is currently moving closer to the line, down from -44.3% last week. With a 14-week RSI of 25, OGI is in oversold territory.
Over the past 14 weeks, down-weeks have had more trading volume than up-weeks (0.62 buyers-vs-sellers ratio). That means when people are active, they're more often selling than buying. Sellers are still more in control than buyers.
Over the past 321 weeks of data, OGI has crossed below its 200-week moving average 4 times. On average, these episodes lasted 77 weeks. The average one-year return after crossing below was -0.8%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $136 million, OGI is a small-cap stock. The company generates a free cash flow yield of 11.9%, which is notably high. Return on equity stands at -5.9%. The stock trades at 0.5x book value.
Share count has increased 80.0% over three years, indicating dilution. This stock also meets the Yartseva multibagger criteria as a small-cap with strong free cash flow yield and reasonable book value.
Over the past 6.2 years, a hypothetical investment of $100 in OGI would have grown to $16, compared to $280 for the S&P 500. OGI has returned -25.4% annualized vs 17.9% for the index, underperforming the broader market over this period.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: OGI vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After OGI Crosses Below the Line?
Across 4 historical episodes, buying OGI when it crossed below its 200-week moving average produced an average return of -21.8% after 12 months (median -47.0%), compared to +12.5% for the S&P 500 over the same periods. 25% of those episodes were profitable after one year. After 24 months, the average return was -63.5% vs +15.5% for the index.
Each line shows $100 invested at the moment OGI crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Bean Score Experimental
The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. OGI currently has negative free cash flow, so price-based dislocation levels are not available. The score still tracks yield deviation from baseline.
Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end
Signal Accuracy Collecting Data
The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"
Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.
Dislocation Scores Experimental
Each score measures deviation from OGI's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.
Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.
Historical Touches
OGI has crossed below its 200-week MA 4 times with an average 1-year return of +-0.8% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Apr 2020 | Feb 2021 | 41 | 65.8% | +77.0% | -83.9% |
| Mar 2021 | Mar 2021 | 1 | 1.7% | -48.5% | -91.0% |
| Apr 2021 | May 2021 | 6 | 12.5% | -31.0% | -90.4% |
| Jun 2021 | Ongoing | 260+ | 83.7% | Ongoing | -91.2% |
| Average | 77 | — | +-0.8% | — |
Frequently Asked Questions
Is OGI below its 200-week moving average?
Yes. As of 2026-06-19, Organigram Global Inc. (OGI) is trading 48.9% below its 200-week moving average of $1.89. The current price is $0.96.
What is OGI's 200-week moving average price?
Organigram Global Inc.'s 200-week moving average is $1.89 as of 2026-06-19. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when OGI drops below its 200-week moving average?
OGI has crossed below its 200-week moving average 4 times in our data. The average one-year return after these crossings was -0.8%, meaning the dips were not reliable buying signals for this particular stock. These episodes lasted 77 weeks on average.
Is OGI a good value right now?
Here's what our data says about OGI as of 2026-06-19: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 25 (oversold). Free cash flow yield is 11.9%. Return on equity is -5.9%. Price-to-book is 0.5x. This is not a buy or sell recommendation — always do your own research.
How does OGI compare to the S&P 500?
Over the past 6.2 years, $100 invested in OGI would have grown to $16, compared to $280 for the S&P 500. That's -25.4% annualized vs 17.9% for the index. OGI has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-06-19